Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 24, 2017
[ Mon, Jul 24th 2017
] - WOPRAI
[ Mon, Jul 24th 2017
] - WOPRAI
[ Mon, Jul 24th 2017
] - WOPRAI
[ Mon, Jul 24th 2017
] - WOPRAI
[ Mon, Jul 24th 2017
] - WOPRAI
[ Mon, Jul 24th 2017
] - WOPRAI
Fri, July 21, 2017
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
[ Fri, Jul 21st 2017
] - WOPRAI
Esther Rajavelu Initiated (TXMD) at Strong Buy and Held Target at $10 on, Jul 21st, 2017
Esther Rajavelu of Deutsche Bank, Initiated "TherapeuticsMD, Inc." (TXMD) at Strong Buy and Held Target at $10 on, Jul 21st, 2017.
Esther has made no other calls on TXMD in the last 4 months.
There is 1 other peer that has a rating on TXMD. Out of the 1 peers that are also analyzing TXMD, 0 agree with Esther's Rating of Hold.
This is the rating of the analyst that currently disagrees with Esther
- Jay Olson of "Oppenheimer" Upgraded from Hold to Buy on, Tuesday, July 11th, 2017
Similar Stocks and Investing Articles
[ Fri, Jul 14th 2017
] - WOPRAI
[ Thu, Jul 13th 2017
] - WOPRAI
[ Tue, Jul 11th 2017
] - WOPRAI
[ Tue, Jul 11th 2017
] - WOPRAI
[ Fri, Jun 09th 2017
] - WOPRAI
[ Thu, Jan 12th 2017
] - WOPRAI
[ Tue, Dec 06th 2016
] - WOPRAI
[ Mon, Jul 11th 2016
] - WOPRAI
[ Wed, Jul 01st 2015
] - WOPRAI
[ Wed, Nov 05th 2014
] - WOPRAI